John B. Henneman III - Director at Aprea Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John B. Henneman III - trading volume in the past year for Aprea Therapeutics, Inc.

Holdings reported by John B. Henneman III for Aprea Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 9,184 $67 K $7.29 Jun 20, 2024 Direct
Stock Options (Right to Buy) 4,185 Jun 20, 2024 Direct Common Stock
Tranche A Warrant 3,430 Mar 13, 2024 Direct Common Stock
Tranche B Warrant 3,430 Mar 13, 2024 Direct Common Stock

Transactions reported by John B. Henneman III for Aprea Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership